The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer

PLoS Pathogens

Volumn 13, Issue 10, 2017, Pages

  Noto, Jennifer M ^a   Peek, Richard M ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACTERIA; ATROPHY; BACTERIAL CLEARANCE; BACTEROIDETES; BURKHOLDERIA; CARCINOGENIC ACTIVITY; CLOSTRIDIUM; COLORECTAL CANCER; DISEASE COURSE; DYSBIOSIS; ESCHERICHIA COLI; FIRMICUTES; FUSOBACTERIUM NUCLEATUM; GASTROINTESTINAL DYSPLASIA; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE METAPLASIA; NONHUMAN; ORGANISMAL INTERACTION; POLYMERASE CHAIN REACTION; PREVOTELLA; PROTEOBACTERIA; REVIEW; STOMACH CANCER; VEILLONELLA; ADENOCARCINOMA; COMPLICATION; DISEASE EXACERBATION; HELICOBACTER INFECTION; MICROBIOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; DISEASE PROGRESSION; GASTROINTESTINAL MICROBIOME; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 85033218411     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006573     Document Type: Review

References (33)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi: 10.1002/ijc.29210 25220842.
2. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI, The human microbiome project. Nature. 2007;449(7164):804–10. doi: 10.1038/nature06244 17943116
3. Human Microbiome Project CStructure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. doi: 10.1038/nature11234 22699609
4. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262–7. doi: 10.1126/science.1223813 22674330.
5. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R, Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30. doi: 10.1038/nature11550 22972295
6. Schwabe RF, Jobin C, The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800–12. doi: 10.1038/nrc3610 24132111
7. Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al.Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22(22):5574–81. doi: 10.1158/1078-0432.CCR-16-1786 27769987.
8. Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, et al.Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol. 2014;20(4):908–22. doi: 10.3748/wjg.v20.i4.908 24574765
9. Sears CL, Garrett WS, Microbes, microbiota, and colon cancer. Cell Host Microbe. 2014;15(3):317–28. doi: 10.1016/j.chom.2014.02.007 24629338
10. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al.Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299–306. doi: 10.1101/gr.126516.111 22009989
11. Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, et al.Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20(4):859–67. doi: 10.1158/1078-0432.CCR-13-1343 24334760.
12. Wang LL, Yu XJ, Zhan SH, Jia SJ, Tian ZB, Dong QJ, Participation of microbiota in the development of gastric cancer. World J Gastroenterol. 2014;20(17):4948–52. doi: 10.3748/wjg.v20.i17.4948 24803806
13. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al.Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A. 2006;103(3):732–7. doi: 10.1073/pnas.0506655103 16407106
14. Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L, Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE. 2008;3(7):e2836. doi: 10.1371/journal.pone.0002836 18665274
15. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, et al.Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5(4):574–9. doi: 10.1038/ismej.2010.149 20927139
16. Dicksved J, Lindberg M, Rosenquist M, Enroth H, Jansson JK, Engstrand L, Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol. 2009;58(Pt 4):509–16. doi: 10.1099/jmm.0.007302-0 19273648.
17. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J, Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. 2014;4:4202. doi: 10.1038/srep04202 24569566
18. Riley DR, Sieber KB, Robinson KM, White JR, Ganesan A, Nourbakhsh S, et al.Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol. 2013;9(6):e1003107. doi: 10.1371/journal.pcbi.1003107 23840181
19. Wang L, Zhou J, Xin Y, Geng C, Tian Z, Yu X, et al.Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur J Gastroenterol Hepatol. 2016;28(3):261–6. doi: 10.1097/MEG.0000000000000542 26657453
20. Eun CS, Kim BK, Han DS, Kim SY, Kim KM, Choi BY, et al.Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods. Helicobacter. 2014;19(6):407–16. doi: 10.1111/hel.12145 25052961.
21. Leung A, Tsoi H, Yu J, Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert Rev Gastroenterol Hepatol. 2015;9(5):651–7. doi: 10.1586/17474124.2015.1001745 25582922.
22. Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, et al.Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000;119(2):339–47. 10930369.
23. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW, Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001;15(3):379–88. 11207513.
24. Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al.Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488–92. doi: 10.1093/jnci/djs003 22271764
25. Robinson KM, Crabtree J, Mattick JS, Anderson KE, Dunning Hotopp JC, Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data. Microbiome. 2017;5(1):9. doi: 10.1186/s40168-016-0224-8 28118849
26. Rolig AS, Cech C, Ahler E, Carter JE, Ottemann KM, The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infect Immun. 2013;81(5):1382–9. doi: 10.1128/IAI.00044-13 23429529
27. Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, et al.Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology. 2011;140(1):210–20. Epub 2010/10/19. doi: 10.1053/j.gastro.2010.09.048 20950613
28. Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, et al.Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63(1):54–63. doi: 10.1136/gutjnl-2013-305178 23812323
29. Lee CW, Rickman B, Rogers AB, Muthupalani S, Takaishi S, Yang P, et al.Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2009;69(20):8166–74. doi: 10.1158/0008-5472.CAN-08-3856 19826057
30. Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, et al.Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology. Infect Immun. 2009;77(5):2147–58. doi: 10.1128/IAI.01395-08 19223483
31. Ge Z, Feng Y, Muthupalani S, Eurell LL, Taylor NS, Whary MT, et al.Coinfection with Enterohepatic Helicobacter species can ameliorate or promote Helicobacter pylori-induced gastric pathology in C57BL/6 mice. Infect Immun. 2011;79(10):3861–71. doi: 10.1128/IAI.05357-11 21788386
32. Nagai S, Mimuro H, Yamada T, Baba Y, Moro K, Nochi T, et al.Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc Natl Acad Sci U S A. 2007;104(21):8971–6. Epub 2007/05/16. doi: 10.1073/pnas.0609014104 17502608.
33. Vogtmann E, Goedert JJ, Epidemiologic studies of the human microbiome and cancer. Br J Cancer. 2016;114(3):237–42. doi: 10.1038/bjc.2015.465 26730578